SANTA CLARA, Calif., April 20 /PRNewswire-FirstCall/ -- XenoPort, Inc. announced today that it will provide access via the world wide web to its presentations at the Deutsche Bank 2006 Health Care Conference and the Morgan Stanley Global Healthcare Unplugged Conference. The company’s Deutsche Bank Conference presentation will occur at 10:45 a.m. Pacific Time (1:45 p.m. Eastern Time) on Wednesday, May 3, 2006. The Morgan Stanley Conference presentation will occur at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on Friday, May 5, 2006. A replay of the presentations will also be available.
To access the live presentations via the web, please go to www.XenoPort.com. Please connect to the website at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.
The replay of each webcast can be accessed on our website for a minimum of one week and will be available approximately 24 hours after the live presentation.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body’s natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort’s most advanced product candidate, XP13512, has commenced a Phase 3 clinical program for the treatment of restless legs syndrome and has successfully completed a Phase 2a clinical trial for the management of post-herpetic neuralgia. XenoPort has also completed two Phase 1 clinical trials of XP19986, a Transported Prodrug of R-baclofen. These trials demonstrated that a prototype formulation of XP19986 was suitable for twice-a-day dosing. XenoPort has commenced a Phase 2a clinical trial of XP19986 in gastroesophageal reflux disease patients.
To learn more about XenoPort, please visit the web site at www.XenoPort.com.
NOTE: XenoPort and Transported Prodrug are trademarks of XenoPort, Inc.
XPNT2G
XenoPort, Inc.
CONTACT: Jackie Cossmon of XenoPort, +1-408-616-7220, or ir@XenoPort.com
Web site: http://www.xenoport.com/
